179 related articles for article (PubMed ID: 38053944)
1. Tenofovir versus Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma After FOLFOX-Hepatic Arterial Infusion Chemotherapy.
Zheng Z; Wang J; Wu T; He M; Wang J; Pan Y; Chen J; Hu D; Xu L; Zhang Y; Chen M; Zhou Z
J Hepatocell Carcinoma; 2023; 10():2117-2132. PubMed ID: 38053944
[TBL] [Abstract][Full Text] [Related]
2. Tenofovir vs. Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma after Radiofrequency Ablation.
Hu Z; Zeng H; Hou J; Wang J; Xu L; Zhang Y; Chen M; Zhou Z
Viruses; 2022 Mar; 14(4):. PubMed ID: 35458386
[TBL] [Abstract][Full Text] [Related]
3. Tenofovir vs. entecavir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative resection.
Wang XH; Hu ZL; Fu YZ; Hou JY; Li WX; Zhang YJ; Xu L; Zhou QF; Chen MS; Zhou ZG
J Gastroenterol; 2022 Mar; 57(3):185-198. PubMed ID: 35152312
[TBL] [Abstract][Full Text] [Related]
4. Tenofovir Versus Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma After Surgical Resection.
Choi J; Jo C; Lim YS
Hepatology; 2021 Feb; 73(2):661-673. PubMed ID: 32324905
[TBL] [Abstract][Full Text] [Related]
5. Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation.
Yang J; Chen Y; Sun H; Zhang X; Wang J; Liang Z; Fu B; Zhang T; Yi S; Deng Y; Yang Y
Infect Agent Cancer; 2023 Jan; 18(1):2. PubMed ID: 36650583
[TBL] [Abstract][Full Text] [Related]
6. Tenofovir versus entecavir on recurrence and mortality of hepatitis B virus-related hepatocellular carcinoma after curative therapy.
Chang KC; Su TH; Liao SH; Tseng TC; Huang SC; Hsu SJ; Hong CM; Liu CH; Yang HC; Liu CJ; Kao JH
J Formos Med Assoc; 2024 Feb; ():. PubMed ID: 38423922
[TBL] [Abstract][Full Text] [Related]
7. Entecavir versus tenofovir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative hepatectomy.
Kao WY; Tan EC; Lee HL; Huang YH; Huo TI; Chang CC; Chiou JF; Hou MC; Wu JC; Su CW
Aliment Pharmacol Ther; 2023 Jun; 57(11):1299-1312. PubMed ID: 36914943
[TBL] [Abstract][Full Text] [Related]
8. Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis.
Liu H; Han CL; Tian BW; Ding ZN; Yang YF; Ma YL; Yang CC; Meng GX; Xue JS; Wang DX; Dong ZR; Chen ZQ; Hong JG; Li T
Expert Rev Gastroenterol Hepatol; 2023; 17(6):623-633. PubMed ID: 37148261
[TBL] [Abstract][Full Text] [Related]
9. Tenofovir Is Superior to Entecavir on Tertiary Prevention for BCLC Stage 0/A Hepatocellular Carcinoma after Curative Resection.
Tsai MC; Wang CC; Lee WC; Lin CC; Chang KC; Chen CH; Hung CH; Lin MT; Hsiao CC; Chen CL; Chien RN; Hu TH
Liver Cancer; 2022 Jan; 11(1):22-37. PubMed ID: 35222505
[TBL] [Abstract][Full Text] [Related]
10. Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores.
Huang Y; Chen L; Huang R; Zhu C; Shang J; Qian Y; Lian J; Liu L; Jiang J; Liu C; Gui H; Xie Q
Ther Adv Chronic Dis; 2022; 13():20406223221102791. PubMed ID: 35757781
[TBL] [Abstract][Full Text] [Related]
11. A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in South Korea.
Kim SU; Seo YS; Lee HA; Kim MN; Lee YR; Lee HW; Park JY; Kim DY; Ahn SH; Han KH; Hwang SG; Rim KS; Um SH; Tak WY; Kweon YO; Kim BK; Park SY
J Hepatol; 2019 Sep; 71(3):456-464. PubMed ID: 30959156
[TBL] [Abstract][Full Text] [Related]
12. Tenofovir versus entecavir for tertiary prevention of hepatocellular carcinoma in chronic hepatitis B infection after curative therapy: A systematic review and meta-analysis.
Giri S; Agrawal D; Afzalpurkar S; Gopan A; Angadi S; Sundaram S
J Viral Hepat; 2023 Feb; 30(2):108-115. PubMed ID: 36321967
[TBL] [Abstract][Full Text] [Related]
13. Risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients receiving tenofovir disoproxil fumarate versus entecavir in the United States.
Kim WR; Telep LE; Jump B; Lu M; Ramroth H; Flaherty J; Gaggar A; Chokkalingam AP; Gordon SC
Aliment Pharmacol Ther; 2022 Apr; 55(7):828-835. PubMed ID: 35137422
[TBL] [Abstract][Full Text] [Related]
14. Tenofovir versus entecavir on the prognosis of hepatitis B-related hepatocellular carcinoma after surgical resection: a randomised controlled trial.
Linye H; Zijing X; Xiaoyun Z; Zhihui L; Tianfu W; Chuan L
Int J Surg; 2023 Oct; 109(10):3032-3041. PubMed ID: 37335984
[TBL] [Abstract][Full Text] [Related]
15. Comparison of tenofovir and entecavir on the risk of hepatocellular carcinoma and mortality in treatment-naïve patients with chronic hepatitis B in Korea: a large-scale, propensity score analysis.
Lee SW; Kwon JH; Lee HL; Yoo SH; Nam HC; Sung PS; Nam SW; Bae SH; Choi JY; Yoon SK; Han NI; Jang JW
Gut; 2020 Jul; 69(7):1301-1308. PubMed ID: 31672838
[TBL] [Abstract][Full Text] [Related]
16. Long-term risk of primary liver cancers in entecavir versus tenofovir treatment for chronic hepatitis B.
Chang TS; Yang YH; Chen WM; Shen CH; Tung SY; Yen CW; Hsieh YY; Lee CP; Tsai ML; Hung CH; Lu SN
Sci Rep; 2021 Jan; 11(1):1365. PubMed ID: 33446835
[TBL] [Abstract][Full Text] [Related]
17. Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B.
Papatheodoridis GV; Dalekos GN; Idilman R; Sypsa V; Van Boemmel F; Buti M; Calleja JL; Goulis J; Manolakopoulos S; Loglio A; Papatheodoridi M; Gatselis N; Veelken R; Lopez-Gomez M; Hansen BE; Savvidou S; Kourikou A; Vlachogiannakos J; Galanis K; Yurdaydin C; Esteban R; Janssen HLA; Berg T; Lampertico P
J Hepatol; 2020 Nov; 73(5):1037-1045. PubMed ID: 32553667
[TBL] [Abstract][Full Text] [Related]
18. The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus-related hepatocellular carcinoma.
Lee JH; Kim BK; Park SY; Tak WY; Park JY; Kim DY; Ahn SH; Sinn DH; Kim SU
Eur J Intern Med; 2021 Jul; 89():48-55. PubMed ID: 33810942
[TBL] [Abstract][Full Text] [Related]
19. Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis.
Huang ZH; Lu GY; Qiu LX; Zhong GH; Huang Y; Yao XM; Liu XH; Huang SJ; Wu T; Yuan Q; Wang YB; Su YY; Zhang J; Xia NS
BMC Cancer; 2022 Mar; 22(1):287. PubMed ID: 35300634
[TBL] [Abstract][Full Text] [Related]
20. Tenofovir Versus Entecavir for the Treatment of Acute-on-Chronic Liver Failure due to Reactivation of Chronic Hepatitis B With Genotypes B and C.
Wan YM; Li YH; Xu ZY; Wu HM; Xu Y; Wu XN; Yang JH
J Clin Gastroenterol; 2019 Apr; 53(4):e171-e177. PubMed ID: 29659382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
